Sales Of Three Major Pharmaceutical Cannabis Products Set To Reach €1.8 Billion By 2025

COMBINED sales of the three most lucrative cannabis pharmaceuticals products – Epidiolex, Dronabinol and Sativex – are set to reach €1.8 billion by 2025, according to a new report. The Pharmaceutical Cannabis Report: 2nd Edition, from global cannabis industry consultants…

Did the DEA’s new rule confirm hemp-derived Delta-8 THC is illegal?

By: Andrea Steel and Lisa Pittman Last Friday, the Drug Enforcement Administration (the “DEA”) published a rule regarding the scheduling of hemp and marijuana, effective immediately (the “Rule”). The cannabis community swiftly reacted with an interpretation that this Rule outlawed…

Marijuana-derived epilepsy drug doubles sales, sending GW Pharma stock soaring

August 7, 2019
AggregatedNews
Cannabis Investments, Medical Marijuana, On the Move
0 Comments

GW Pharmaceuticals PLC reported Tuesday afternoon that sales of its cannabis-derived epilepsy drug more than doubled from the previous quarter, sending shares spiking more than 11% higher in after-hours trading. GW Pharmaceuticals GWPH, +10.22% reported second-quarter sales of $68.4 million for Epidiolex, which uses…

Big Pharma is Coming for the Cannabis Industry

January 5, 2019
John Taenzler
Medical Marijuana, Science and Technology
0 Comments

In a recent double-blinded study [1] examining the attitudes of pain specialists and oncologists toward the use of MMJ, only 38% of these physicians in the USA are recommending MMJ to their patients for treating the symptoms of their disease and/or…

GW Pharmaceuticals plc Reports Fiscal Fourth Quarter and Year-End 2018 Financial Results and Operational Progress

December 7, 2018
Press Release
Banking, Finance & Real Estate, Press Releases, Science and Technology
0 Comments

PRESS RELEASE Epidiolex® (cannabidiol) oral solution (CV), first FDA-approved plant-derived cannabinoid medicine launched in the U.S. - Conference call today at 4:30 p.m. EST - LONDON and CARLSBAD, Calif., Nov. 27, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ: GWPH,…

DEA reclassifies plant-derived marijuana medicine

According to a release issued by the National Organization for the Reform of Marijuana Laws, Epidiolex, a prescription medicine containing a standardized formulation of plant-derived cannabidiol (CBD), has been reclassified by the U.S. Drug Enforcement Administration to Schedule V — the lowest restriction…

First FDA approved cannabis-based drug now available by prescription

The first cannabis-derived medication approved by the Food and Drug Administration is now available by prescription in every state, according to its manufacturer. Epidiolex, manufactured by GW Pharmaceuticals, is intended to treat seizures associated with two rare and severe forms of…

Will the FDA/DEA Epidiolex Rulings and the 2018 Farm Bill Change the Industry?

In late June 2018, the Food and Drug Administration announced approval for a new medication that could potentially change the way the world views cannabis. Epidiolex is a CBD-based oral solution that is prescribed to treat two forms of rare…

The drug maker behind the first FDA-approved medication derived from marijuana has revealed how much it’ll cost

A marijuana-derived drug that recently became the first of its kind to win federal approval is not going to be cheap. Called Epidiolex, the drug is designed to treat two rare forms of childhood epilepsy using a cannabis compound called…

Buzzkill Alert: California Prohibits Hemp CBD In Food

California is essentially letting the FDA dictate what it will do with hemp CBD. Earlier this month, the California Department of Public Health’s Food and Drug Branch (CDPH-FDB) issued a revised FAQ on cannabidiol (CBD) in food products. Per these FAQs…

The Federal Government has acknowledged a patent on a cannabis based pharmaceutical as a legitimate and useful medicine

G.W. Pharmaceuticals accomplished a feat that is about to change the course of history. They achieved drug approval for a plant-based medicine related to cannabis for treatment of certain conditions in children! This doesn’t apply only to states that have…

The FDA Just Approved the First-Ever Cannabis Based Drug in the U.S.

The Food and Drug Administration (FDA) for the first time approved a drug directly derived from cannabis on Monday, Epidiolex, developed by the British GW Pharmaceuticals. Although several states have legalized the medical and recreational use of marijuana, the federal…

Don’t Expect Joints If the FDA Ever Approves Medical Marijuana

While past marijuana opponents like John Boehner are coming around to legal weed, the Food and Drug Administration isn’t likely to recommend that Americans light up a joint anytime soon. That doesn’t mean that cannabis will never be sanctioned by…